About Sorin Group
Sorin Group is a company based in Milan (Italy) founded in 1956 was acquired by Cyberonics in February 2015. Sorin Group has completed 2 acquisitions, including Gish Biomedical and Oscor. Sorin Group operates in a competitive market with competitors including AtaCor Medical, Kestra Medical Technologies, CardioFocus, AtriCure and TyRx, among others.
- Headquarter Milan, Italy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$499.59 K (USD), Grant
Jan 01, 2016
-
Investors
European Union
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Gish Biomedical
& 1 more
-
Acquired by
Cyberonics
(Feb 26, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sorin Group
Investors in Sorin Group
Sorin Group has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Cyberonics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Vagus nerve stimulation therapy is developed for epilepsy and depression.
|
Locked | Locked | Locked |
Investor details for Sorin Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sorin Group
Sorin Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Gish Biomedical and Oscor.
Investment portfolio details for Sorin Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Managed services for AI and VDI digital workspaces are provided.
|
Locked | Locked | 1982 | Locked | |
|
Manufacturer of traditional Italian gianduia chocolates and confectionery
|
Locked | Locked | 1976 | Locked |
Complete acquisition details for Sorin Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sorin Group
Detailed financials for Sorin Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sorin Group Comparisons
Peer comparison for Sorin Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sorin Group
Sorin Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, Kestra Medical Technologies, CardioFocus, AtriCure and TyRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
Antibacterial envelopes are developed for stabilizing cardiac implantable devices.
|
|
| Locked | Locked | Locked |
Non-invasive treatments for cardiac arrhythmias are developed by EBAMed.
|
Detailed competitors of Sorin Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sorin Group
Complete news archive for Sorin Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sorin Group
Sorin Group was founded in 1956 and raised its 1st funding round 60 years after it was founded.
Sorin Group is headquartered in Milan, Italy. It is registered at Milan, Lombardy, Italy.
Sorin Group d.b.a LivaNova, is a medical device company that develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. The products offered include two major therapeutic areas: Cardiac Surgery (cardiopulmonary products for open heart surgery and heart valve repair or replacement prostheses) and Cardiac Rhythm Management (pacemakers, defibrillators and non invasive monitoring to diagnose arrhythmias and deliver anti-arrhythmia therapies as well as cardiac resynchronization devices for heart failure treatment). Claims that every year, over one million patients are treated with Sorin Group devices in more than 100 countries. Currently, the company is investing in the development of new therapies in the field of Heart Failure and Mitral Regurgitation. Received the Compliance Award in Italy - Sorin Group is recognized as having the Best Compliance Program by Top Legal Corporate Counsel Awards in 2015. Acquired Oscor in March, 2014 for 20M and also invested 20M in Respicardia and 8M in Cardiosolutions. Was acquired by Cyberonics on February 26, 2015.
Sorin Group's top competitors include AtaCor Medical, AtriCure and CardioFocus.
Sorin Group has made 2 acquisitions, including Gish Biomedical, and Oscor.
Sorin Group has 2 investors. Key investors include European Union, and Cyberonics.